MUWRP celebrated 10 years of progress in research and HIV prevention, treatment and care at a ceremony held at the College of Health Sciences quadrangle in Kampala.
In the 30 May issue of The Lancet Infectious Diseases, MHRP researchers and collaborators provide important insights on behavioral and time variables that may have influenced the efficacy seen in the RV144 HIV vaccine study.
Today, the U.S. military continues to pursue the goal of developing a globally effective HIV vaccine to assist in the eventual eradication of HIV/AIDS.
Researchers have discovered important clues about the immune responses that may have played a role in protecting some volunteers from HIV in the RV144 Thai trial.
